DSIJ Mindshare

AstraZeneca Pharma India Limited announced that it has received import and marketing permission in form CT-20 from Drugs Controller General of India (DCGI) for Acalabrutinib 100 mg capsules (Calquence).

On Thursday, Sequent Scientific, a company with businesses across animal health and analytical services, announced receipt of approval from World Health Organisation (WHO) Geneva, for its API Praziquantel (Anthelmintic) under a pre-qualification program at its Visakhapatnam site.

On Wednesday, Adani Enterprises informed the bourses that the company led consortium received an LOA from National Highways Authority of India (NHAI) for a hybrid annuity road project worth Rs 1,546.31 crore. With this project, Adani Group will have a total of four NHAI road projects under Hybrid Annuity Model (HAM) spanning in the state of Chhattisgarh, Telangana and Andhra Pradesh.

On Monday, value-added engineering solutions company, Pennar Industries informed the bourses that it has won total orders to the tune of Rs 550 crore for the month of February 2020. The orders received were spread amongst the company's pre-engineered buildings, railways, steel, tubes and industrial component division.

On Monday, drug firm-Zydus Cadila announced that it has entered into a licencing agreement with XOMA Corporation to advance an IL-2 based Immuno-Oncology (IO) drug candidate which combines Zydus' IL-2 with XOMA's novel anti-IL-2 monoclonal antibody.